Replies to post #1892 on Fresenius Kabi Pharmaceuticals (APCVZ)

[sigma_x]

Now I Have a Question - I hope that cleared up a lot of confusion for you guys. I know it did for me. And I look at this as good news, if you're long (as I am - despite what a simpleton like Ka-Ching might have you believe.)

Now, my question is - what's the avg that these guys have reported as EBITDA for the last, say, 3 qtrs? That's the most important factor right there. The whole deal started in 2008 - by the time Dec. 31st rolls around, it'll be 3 years, total.) So the whole deal calls for them to make $1.67 Bln in 3 years as EBITDA. They are $531 mln away. So it's taken them a little over two years to get over 2 1/3rds of the way there.

They just increased their chances significantly with this news.

And, what a lot of people haven't taken into consideration, is THIS bit of news, that just came out earlier this month, and, I think, will have a HUGE impact on their adjusted EBITDA.

You be the judge.

http://www.avma.org/onlnews/javma/may10/100515c.asp

But, still, what's the avg quarterly EBITDA for these guys for the last 3 or 4 qtrs.?

Thx.